Novartis CEO Says New Purchases Will Boost Sales

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

Japan Wage Growth Stagnates
37:32 - Japan’s workers barely got a pay rise in 2015, with a 0.1 percent increase in cash earnings slower than the 0.4 percent bump in 2014. Total wages in Japan haven’t risen more than 1 percent in any year since 1997 and they fell for the past four years once inflation is accounted for, the labor ministry said on Monday in Tokyo. Bloomberg’s James Mayger and UBS Head of Global Asset Allocation Mads Pedersen joined Bloomberg’s Manus Cranny and Anna Edwards on “Countdown” for further analysis.
  • Vitol CEO Sees Oil Priced Between $40 - $60 For a Decade
  • How Long Will Chinese Growth Rates Decline For?
  • Twitter: Bloomberg West (Full Show 02/05)